Related Experiment Videos

Essential myosin light chain as a target for caspase-3 in failing myocardium

Alessandra Moretti1, Hans-Jörg Weig, Thomas Ott

  • 1I. Medizinische Klinik and Deutsches Herzzentrum, D-81675 Munich, Germany.

Insights

Activated caspase-3 cleaves ventricular essential myosin light chain (vMLC1) in heart failure, disrupting sarcomeres and reducing contractility. Inhibiting caspase-3 improves cardiac function, suggesting apoptosis contributes to heart dysfunction before cell death.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Programmed cell death involves caspase proteases cleaving cytoskeletal proteins.
  • Caspase-3 activation is linked to reduced contractile performance in failing cardiac myocytes.

Purpose of the Study:

  • To identify cardiac cytoskeletal proteins interacting with caspase-3.
  • To investigate the role of ventricular essential myosin light chain (vMLC1) cleavage in cardiac dysfunction.

Main Methods:

  • Modified yeast two-hybrid system screening for caspase-3 interacting proteins.
  • Sequencing and site-directed mutagenesis to map vMLC1 cleavage site.
  • Adenoviral gene transfer of caspase inhibitor p35 in vivo.

Main Results:

  • Ventricular essential myosin light chain (vMLC1) identified as a caspase-3 target at the DFVE(135)G motif.
  • vMLC1 cleavage in failing myocardium disrupts sarcomere organization and reduces myocyte contractility.
  • p35 inhibition of caspase-3 prevented vMLC1 cleavage and improved cardiac contractility.

Conclusions:

  • Direct cleavage of vMLC1 by caspase-3 contributes to cardiac contractile dysfunction.
  • Apoptotic pathway activation in the heart can impair myocyte function prior to cell death.

Related Concept Videos